Sector revisions Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq 01:30:00 01/10/2026 am IST			After hours 01:51:16 am
522.81 ^USD	-0.74%		526.70	+0.74%

28/09	UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating	MT
23/09	TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	VERTEX PHARMACEUTICALS INCORPORATED							28
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	MERCK & CO., INC.							25
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							26
	NOVO NORDISK A/S							23
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	MCKESSON CORPORATION							14
	GSK PLC							21
	SANOFI							24
	MODERNA, INC.							18
	REGENERON PHARMACEUTICALS, INC.							26
	MERCK KGAA							14
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	Average							23
	Weighted average by Cap.							25